ANI PHARMACEUTICALS INC
ANIPLatest QuantConomy context for ANIP: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
20
Asset profile
ANI PHARMACEUTICALS INC
QuantConomy has a structured record for ANIP. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- ANIP
- Name
- ANI PHARMACEUTICALS INC
- Coverage
- 3 market/data records
- Sources
- alphavantage alpaca fmp sec nasdaq openfigi
Latest signal rows
Recent signals for ANIP
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings release | neutral | 40 | Jan 12, 12:00 AM | ANIP filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-01-12. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| earnings release | neutral | 40 | Feb 27, 12:00 AM | ANIP filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-27. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| earnings release | neutral | 40 | May 8, 12:00 AM | ANIP filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-05-08. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| ANIP | NASDAQ | alphavantage | ANI Pharmaceuticals Inc |
| ANIP | NASDAQ | alpaca | ANI Pharmaceuticals, Inc. |
| ANIP | NASDAQ | fmp | ANI Pharmaceuticals, Inc. |
Recent insider transactions
Buys, last 90d
0
Sells, last 90d
8
Rows
20
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | CAREY STEPHEN P. | SVP & CFO | exercise | 3,313 | $49.51 | $164,027 | 4 on EDGAR |
| Jun 29, 2026 | CAREY STEPHEN P. | SVP & CFO | sale | 2,850 | $84.12 | $239,742 | 4 on EDGAR |
| Jun 12, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | sale | 500 | $82.03 | $41,015 | 4 on EDGAR |
| Jun 5, 2026 | CAREY STEPHEN P. | SVP & CFO | exercise | 3,312 | $49.51 | $163,977 | 4 on EDGAR |
| May 21, 2026 | TANNENBAUM RENEE P | Insider | grant | 4,357 | $0.00 | $0 | 4 on EDGAR |
| May 21, 2026 | Pera Antonio R | Insider | grant | 4,357 | $0.00 | $0 | 4 on EDGAR |
| May 21, 2026 | HAUGHEY THOMAS | Insider | grant | 4,357 | $0.00 | $0 | 4 on EDGAR |
| May 21, 2026 | Leonard Matthew J | Insider | grant | 4,357 | $0.00 | $0 | 4 on EDGAR |
| May 21, 2026 | Thoma Jeanne | Insider | grant | 4,357 | $0.00 | $0 | 4 on EDGAR |
| May 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | sale | 500 | $78.16 | $39,080 | 4 on EDGAR |
| May 12, 2026 | Gutwerg Ori | SVP, GENERICS | sale | 2,772 | $79.50 | $220,374 | 4 on EDGAR |
| May 12, 2026 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | sale | 459 | $79.21 | $36,357 | 4 on EDGAR |
| May 11, 2026 | Walsh Patrick D | Insider | sale | 3,973 | $80.75 | $320,820 | 4 on EDGAR |
| May 11, 2026 | Lalwani Nikhil | PRESIDENT & CEO | sale | 55,000 | $77.57 | $4,266,350 | 4 on EDGAR |
| Apr 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | sale | 500 | $77.95 | $38,975 | 4 on EDGAR |
| Mar 13, 2026 | Mutz Christopher | HEAD OF RARE DISEASE | sale | 3,162 | $71.64 | $226,526 | 4 on EDGAR |
| Mar 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | sale | 500 | $72.62 | $36,310 | 4 on EDGAR |
| Mar 11, 2026 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | sale | 4,772 | $74.91 | $357,471 | 4 on EDGAR |
| Mar 7, 2026 | Gutwerg Ori | SVP, GENERICS | other | 3,314 | $74.04 | $245,369 | 4 on EDGAR |
| Mar 7, 2026 | Lalwani Nikhil | PRESIDENT & CEO | other | 17,060 | $74.04 | $1,263,122 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Get the data
Query ANIP context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access